All Posts

For Patients at Intermediate Cardiovascular Risk Cardiovascular disease remains a leading cause of mortality worldwide. Early and accurate identification of coronary artery disease (CAD) allows clinicians to tailor preventive strategies effectively. However, the choice of screening modality matters — especially in people with intermediate cardiovascular risk , where diagnostic clarity can influence preventive and therapeutic decisions. In this post, we unpack the evidence com

In Dr. Marsden’s Year in Review: Key Research Developments Shaping Clinical Practice in 2025, I bring together the most clinically relevant advances published over the past year across integrative and preventive medicine. This review highlights a clear shift toward precision, personalization, and systems-based care, with focused insights into hormone replacement therapy, gut–brain–endocrine interactions, physical activity as a therapeutic intervention in oncology, and emergin

A comprehensive cardiometabolic assessment goes beyond standard labs to uncover insulin resistance, inflammation, lipid particle risk, hormonal influences, and autonomic balance—providing a clearer picture of the drivers of cardiometabolic health.